HIV 1 News and Research

RSS

In move to slash CDC budget, House Republicans target major HIV program Trump launched

More than four years ago, then-President Donald Trump declared an ambitious goal that had bipartisan support: ending the HIV epidemic in the United States.

8 Sep 2023

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Researchers elucidated monkeypox's (mpox) epidemiological and clinical features.

8 Sep 2023

Novel test could improve detection of cervical adenocarcinoma

In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss.

7 Sep 2023

Study uncovers thousands of medication pairings linked to frequent dosage adjustments

Researchers investigated the complexity of polypharmacy and whether frequent dose adjustments were required for co-medications and drug pairs in hospital settings.

7 Sep 2023

One in three men carry HPV: The ignored reservoir in the fight against cancer

One in three men over 15 globally have at least one incidence of genital HPV, underscoring the need to include males in HPV prevention strategies. The prevalence remains high from young adulthood through later life, particularly for high-risk HPV types linked to cancers.

6 Sep 2023

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers used a SARS-CoV-2 spike protein-pseudotyped viral model to characterize BA.2.86 variant neutralization by monoclonal antibodies.

6 Sep 2023

World-renowned Diamond Light Source facility to be upgraded through a £500 million investment

A groundbreaking science facility which kickstarted the UK's world leading Covid drug development and has advanced treatments of global health challenges from HIV to malaria and cancer will be upgraded and expanded through a more than £500 million investment, Science and Technology Secretary Michelle Donelan has announced today (Wednesday 6 September).

5 Sep 2023

Workers pay the price while Congress and employers debate need for heat regulations

Sometimes the heat makes you vomit, said Carmen Garcia, a farmworker in the San Joaquin Valley of California. She and her husband spent July in the garlic fields, kneeling on the scorched earth as temperatures hovered above 105 degrees.

5 Sep 2023

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

New research from Boston Medical Center found that providing pragmatic support, specifically rapid access to antiretroviral therapy, pharmacotherapy for opioid use disorder, and strengths-based case management, improved treatment outcomes for people with HIV who inject drugs in St. Petersburg, Russia.

1 Sep 2023

Dectin-1 stimulation promotes pro-inflammatory response in HIV-positive individuals

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 16, entitled, "Dectin-1 stimulation promotes a distinct inflammatory signature in the setting of HIV-infection and aging."

31 Aug 2023

Study finds potential HIV cure using existing cancer drug

An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease.

30 Aug 2023

New mechanism of action discovered for pulmonary distress in immunocompromised patients

When an immunocompromised person's system begins to recover and produce more white blood cells, it's usually a good thing – unless they develop a potentially deadly inflammatory condition.

30 Aug 2023

A move to cut drug prices has patients with rare diseases worried

For people with cystic fibrosis, like Sabrina Walker, Trikafta has been a life-changer.

30 Aug 2023

Higher dose and shorter treatment of key antibiotic proven to be safe for TB patients

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of London and results published in NEJM Evidence.

29 Aug 2023

Using community-based digital intervention to protect Tanzanian children from preventable infections

Jan Ostermann, associate professor of health services policy and management, is leading a new project to increase vaccination uptake among children in rural and underserved areas.

28 Aug 2023

NIH and VentureWell select winners and honorable mentions of the DEBUT Challenge

The National Institutes of Health and the higher education non-profit VentureWell have selected 10 winners and five honorable mentions of the Design by Biomedical Undergraduate Teams (DEBUT) Challenge, who are set to receive prizes totaling $145,000.

25 Aug 2023

Cholesterol loss in inner ear linked to age-related hearing loss

Researchers led by María Eugenia Gomez-Casati, the Institute of Pharmacology, School of Medicine, University of Buenos Aires-CONICET; Mauricio Martin, the Institute of Medical Research Mercedes; and Martín Ferreyra, (INIMEC-CONICET-UNC), National University of Córdoba in Argentina report that age-related hearing loss is associated with a decrease of cholesterol in the inner ear.

24 Aug 2023

Study explores lipid and metabolic alterations in HIV/TB co-infected patients

Researchers investigated the differential impact of HIV/tuberculosis co-infection on lipid and metabolic profiles.

23 Aug 2023

Aspirin underutilized for preventing heart attack, stroke

For people who have experienced a heart attack or stroke, taking a daily aspirin has been shown to help prevent a second one.

22 Aug 2023

Strengthening prison reentry programs can help reduce opioid overdose deaths in the U.S.

With opioid overdose deaths surging in the United States, many communities are in desperate need of solutions to bring down the body count. Among the most promising is strengthening prison reentry programs for highest-risk users, a Rutgers-led study has found.

21 Aug 2023

HIV 1 News and Research

In move to slash CDC budget, House Republicans target major HIV program Trump launched

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Novel test could improve detection of cervical adenocarcinoma

Study uncovers thousands of medication pairings linked to frequent dosage adjustments

One in three men carry HPV: The ignored reservoir in the fight against cancer

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

World-renowned Diamond Light Source facility to be upgraded through a £500 million investment

Workers pay the price while Congress and employers debate need for heat regulations

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

Dectin-1 stimulation promotes pro-inflammatory response in HIV-positive individuals

Study finds potential HIV cure using existing cancer drug

New mechanism of action discovered for pulmonary distress in immunocompromised patients

A move to cut drug prices has patients with rare diseases worried

Higher dose and shorter treatment of key antibiotic proven to be safe for TB patients

Using community-based digital intervention to protect Tanzanian children from preventable infections

NIH and VentureWell select winners and honorable mentions of the DEBUT Challenge

Cholesterol loss in inner ear linked to age-related hearing loss

Study explores lipid and metabolic alterations in HIV/TB co-infected patients

Aspirin underutilized for preventing heart attack, stroke

Strengthening prison reentry programs can help reduce opioid overdose deaths in the U.S.

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News